case_images: PMC9381861_01
case_images: (A) Computed tomography scans with typical ground glass opacities (white arrows) and consolidation (asterix) predominantly on posterobasal regions, (B) control thorax tomography after 5 months.
case_images: fmed-09-934169-g001.jpg
case_images: PMC9381861_01_fmed-09-934169-g001.jpg
case_images: F1
case_images: CT-scans showed typical ground glass opacities consistent with COVID-19 pneumonia, the infiltration involved approximately 40% of the lung parenchyma (Figure 1A). After 5 months her follow-up CT showed marked improvement (Figure 1B).
case_images: Time course of COVID symptoms and treatments, inflammation levels and peripheral oxygenation during COVID-19 infection. Day 0, COVID-19 symptoms started; Day 7, inpatient clinic + Casivirimab-imdevimab treatment; Day 9, transferred to COVID clinic-Baricitinib 4 mg added; Day 11, steroid treatment added; Day 18, discharge.
case_images: fmed-09-934169-g002.jpg
case_images: PMC9381861_01_fmed-09-934169-g002.jpg
case_images: F2
case_images: After 7th day of hospitalization her clinical status started to improve, oxygen demand decreased and CRP level (10 mg/L) and IL-6 level (13 pg/mL) decreased (Figure 2). On the 11th day she was discharged from the hospital (Figure 2).